These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16704988

  • 1. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
    Wang LG, Liu XM, Chiao JW.
    Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
    [Abstract] [Full Text] [Related]

  • 2. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.
    Yu C, Gong AY, Chen D, Solelo Leon D, Young CY, Chen XM.
    Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605
    [Abstract] [Full Text] [Related]

  • 3. Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation.
    Beklemisheva AA, Feng J, Yeh YA, Wang LG, Chiao JW.
    Prostate; 2007 Jun 01; 67(8):863-70. PubMed ID: 17431886
    [Abstract] [Full Text] [Related]

  • 4. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
    Kim SH, Singh SV.
    Mol Cancer Ther; 2009 Jul 01; 8(7):1946-54. PubMed ID: 19584240
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH.
    Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070
    [Abstract] [Full Text] [Related]

  • 6. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW.
    Int J Oncol; 2008 Aug 15; 33(2):375-80. PubMed ID: 18636159
    [Abstract] [Full Text] [Related]

  • 7. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 15; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 8. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H, Gong A, Young CY.
    Carcinogenesis; 2005 Apr 15; 26(4):793-801. PubMed ID: 15661808
    [Abstract] [Full Text] [Related]

  • 9. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

  • 10. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.
    Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539
    [Abstract] [Full Text] [Related]

  • 11. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
    Xiao J, Gong AY, Eischeid AN, Chen D, Deng C, Young CY, Chen XM.
    Prostate; 2012 Oct 01; 72(14):1514-22. PubMed ID: 22314666
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 01; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS, Li W, Fuentes F, Guo Y, Ramirez CN, Gonzalez XP, Pung D, Kong AN.
    Pharmacol Res; 2016 Dec 01; 114():175-184. PubMed ID: 27818231
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 15. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
    Gong A, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY.
    Mol Nutr Food Res; 2009 Jul 15; 53(7):878-86. PubMed ID: 19437484
    [Abstract] [Full Text] [Related]

  • 16. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate.
    Chiao JW, Chung F, Krzeminski J, Amin S, Arshad R, Ahmed T, Conaway CC.
    Int J Oncol; 2000 Jun 15; 16(6):1215-9. PubMed ID: 10811998
    [Abstract] [Full Text] [Related]

  • 17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 18. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
    Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z.
    Cancer Res; 2007 Feb 01; 67(3):967-75. PubMed ID: 17283128
    [Abstract] [Full Text] [Related]

  • 19. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.
    Tang NY, Huang YT, Yu CS, Ko YC, Wu SH, Ji BC, Yang JS, Yang JL, Hsia TC, Chen YY, Chung JG.
    Anticancer Res; 2011 May 01; 31(5):1691-702. PubMed ID: 21617228
    [Abstract] [Full Text] [Related]

  • 20. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Oncogene; 2004 Jul 01; 23(30):5175-84. PubMed ID: 15156193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.